Department of Diagnostics and Public Health, Section of Forensic Medicine, University of Verona, Verona, Italy.
U.O. Patologia Clinica, Laboratorio Unico, AUSL Romagna, Cesena, Italy.
J Pharm Biomed Anal. 2018 Mar 20;151:71-74. doi: 10.1016/j.jpba.2017.12.059. Epub 2018 Jan 3.
Although recent Cannabis use is widely reported to be associated with drug-related traffic accidents, the evidence that Cannabis users show an increased risk of being involved in road crashes is still not unequivocally proved. The purpose of the present work is to provide an objective assessment of this hypothesis, by comparing the frequency of occurrence of positive urine analyses in drivers involved in traffic accidents (n = 1406) with that observed in a control population undergoing mandatory urine drug testing (n = 1953). Urine analyses for drugs of abuse were performed by screening immunometric techniques followed by confirmation with UHPLC-QQQ MS, adopting a cut-off concentration for THC-COOH of 15 ng/mL. A case was classified as "positive" when a driver admitted to hospital for road traffic injuries showed urine concentrations of THC-COOH higher than the cut-off. All samples showing positive results for any other controlled drug in urine or blood alcohol concentrations >0.5 mg/mL were excluded from the study. Subjects positive to THC-COOH, and negative to all the other tested substances were 116 in Group 1 (8.2%) and 16 in Group 2 (0.8%). Subjects resulting negative to any tested substances were 1290 in Group 1 and 1937 in Group 2. The frequency of THC-COOH detection in the two groups was compared by using the "chi square" test, which resulted = 119.57, i.e. highly significant (P <<< 0.01). The Odds Ratio of the two groups was =10.88, showing a high degree of association between the presence of THC-COOH in urine and the occurrence of traffic accidents (P < 0.0001). The presented data, proving a high degree of association between Cannabis use and the occurrence of traffic accidents with injuries of the driver, support the use of urine testing for Cannabis in the procedures for the issuing of the driving licence, particularly in the case of subjects formerly or presently using Cannabis. This finding looks even more relevant in the present times, because of the increasing success of the policies of legalization of Cannabis for medical and non-medical purposes.
尽管最近有报道称大麻的使用与与药物相关的交通事故广泛相关,但大麻使用者发生道路碰撞的风险增加的证据仍然没有得到明确证实。本研究的目的是通过比较参与交通事故的驾驶员(n=1406)尿液分析阳性的发生率与强制性尿液药物检测(n=1953)的发生率,客观评估这一假设。滥用药物的尿液分析采用筛选免疫测定技术进行,然后用 UHPLC-QQQ MS 进行确认,采用 15ng/mL 的 THC-COOH 截断浓度。当因道路交通伤害住院的驾驶员尿液中 THC-COOH 浓度高于截断浓度时,将病例分类为“阳性”。所有尿液中检测到其他任何受控药物呈阳性或血液酒精浓度>0.5mg/mL 的样本均被排除在研究之外。在第 1 组(8.2%)中,THC-COOH 阳性且所有其他测试物质均为阴性的受试者有 116 人,在第 2 组(0.8%)中,THC-COOH 阴性且所有其他测试物质均为阴性的受试者有 16 人。在第 1 组和第 2 组中,对任何测试物质均呈阴性的受试者分别为 1290 人和 1937 人。使用“卡方”检验比较两组中 THC-COOH 的检测频率,结果为 119.57,即非常显著(P<<<0.01)。两组的优势比为 10.88,表明尿液中 THC-COOH 的存在与交通事故的发生之间存在高度关联(P<0.0001)。所提供的数据证明大麻使用与驾驶员受伤的交通事故之间存在高度关联,支持在驾驶执照发放程序中使用尿液检测大麻,特别是对于以前或现在使用大麻的受试者。由于大麻的合法化政策在医疗和非医疗用途方面取得了越来越大的成功,这一发现看起来更加相关。